Ahlehoff O, 20113030 Ahlehoff O, Gislason GH, Lindhardsen J, Olesen JB, Charlot M, Skov L, et al. Prognosis following first-time myocardial infarction in psoriatic patients: a Danish nationwide cohort study. J Intern Med. 2011;270:237–44.
|
Danish |
2002 – 2006 |
The Danish National Patient Register |
69.5 (12.1); 36.58 |
70.6 (13.5); 38.72 |
462 |
199 |
48935 |
20356 |
CVD, KD, PD |
6 |
Ahlehoff O, 20123131 Ahlehoff O, Gislason GH, Jørgensen CH, Lindhardsen J, Charlot M, Olesen JB, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. Eur Heart J. 2012;33:2054–64.
|
Danish |
1997.01 – 2006.12 |
The Danish National Patient Register |
46.1 ± 16.9; 49.72 |
43.7 ± 19.7; 49.03 |
39558 |
530 |
4478926 |
55660 |
CVD, KD, CD, PD |
7 |
Armstrong AW, 20133232 Armstrong AW, Azizi S, Wu J, Harskamp CT, Farrow J, Johnson MAN, et al. Psoriasis, electrocardiographic characteristics, and incidence of atrial fibrillation. Arch Dermatol Res. 2013;305:891–7.
|
US |
2004 – 2009 |
University of California Davis |
53 (40–63); 59.19 |
53 (40–63); 51.11 |
2078 |
1776 |
6234 |
3616 |
CVD, CD, PD |
6 |
Charlton R, 20183333 Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, et al. Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study. Rheumatology (Oxford). 2019;58:144–8.
|
UK |
1998.01 – 2014.12 |
The UK Clinical Practice Research Datalink |
49 (39–59); 50.95 |
49 (39 –59); 50.95 |
27132 |
8444 |
27132 |
7051 |
CVD, CD |
7 |
Chiang CH, 20113434 Chiang CH, Huang CC, Chan WL, Huang PH, Chen YC, Chen TJ, et al. Psoriasis and increased risk of ischemic stroke in Taiwan: a nationwide study. J Dermatol. 2012;39:279–81.
|
Taiwan |
Before 2007 |
Longitudinal Health Insurance Database 2007 |
45.3 ± 17.4; 43.69 |
43.5 ± 17.4; 22.14 |
2783 |
1066 |
13910 |
5145 |
CVD, KD |
6 |
Feldman SR, 20153535 Feldman SR, Zhao Y, Shi L, Tran MH. Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis. J Manag Care Spec Pharm. 2015;21:874–88.
|
US |
2007.01 – 2012.03 |
The OptumHealth Reporting and Insights claims database |
47.62; 44.50 |
47.62; 44.50 |
5492 |
881 |
5492 |
499 |
KD, CD, PD, LD |
7 |
Khalid U, 20153636 Khalid U, Ahlehoff O, Gislason GH, Skov L, Torp-Pedersen C, Hansen PR. Increased risk of aortic valve stenosis in psoriatic patients: a nationwide cohort study. Eur Heart J. 2015;36:2177–83.
|
Danish |
1997.01 – 2011.12 |
The Danish National Patient Register |
43.3 (15.8); 51.48 |
41.9 (19.9); 5 0.71 |
70665 |
1292 |
5036959 |
105321 |
CVD, KD, PD |
7 |
Lee S, 20173737 Lee S, Xie L, Wang Y, Vaidya N, Baser O. Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population. J Med Econ. 2018;21:564–70.
|
US |
2010.11 – 2015.10 |
The US Department of Defense population |
48.1; 51.84 |
48.1; 51.84 |
7249 |
2932 |
72490 |
22367 |
CVD, CD |
7 |
Min C, 20192626 Min C, Lim H, Lim JS, Sim S, Choi HG. Increased risk of migraine in psoriatic patients: A longitudinal follow up study using a national sample cohort. Medicine (Baltimore). 2019;98:e15370.
|
Korean |
2002 – 2013 |
The Korean National Health Insurance Service-National Sample Cohort |
NR; 43.32 |
NR; 43.32 |
11071 |
5187 |
44284 |
20298 |
CVD, CD |
7 |
Prasada S, 20202929 Prasada S, Rivera A, Nishtala A, Pawlowski AE, Sinha A, Bundy JD, et al. Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure. JACC Heart Fail. 2020;8:489–98.
|
US |
2000.01 – 2019.01 |
The Northwestern Medicine Enterprise Data Warehouse |
49.72 (15.95); 51.71 |
48.60 (16.65); 57.34 |
5365 |
1536 |
19358 |
5241 |
CVD, KD |
7 |
Schell C, 20153838 Schell C, Schleich R, Walker F, Yazdi AS, Lerche H, Röcken M, et al. Restless legs syndrome in psoriasis: an unexpected comorbidity. Eur J Dermatol. 2015;25:255–60.
|
German |
NR |
Eberhard Karls University Tübingen |
48.3 ± 15.6; 43.33 |
49.1 ± 18.6; 60.00 |
300 |
158 |
300 |
150 |
CVD, KD, PD, LD |
6 |
Tollefson MM, 20182828 Tollefson MM, Houten HK, Asante D, Yao X, Kremers HM. Association of Psoriasis With Comorbidity Development in Children With Psoriasis. JAMA Dermatol. 2018;154:286–92.
|
US |
2004.01 – 2013.12 |
Optum Laboratories Data Warehouse |
12.0 (4.4); 53.52 |
12.0 (4.4); 53.52 |
29957 |
1200 |
29957 |
646 |
CVD, LD |
8 |
Vena GA, 20103939 Vena GA, Altomare G, Ayala F Berardesca E, Calzavara-Pinton P, Chimenti S, et al. Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol. 2010;20:593–8.
|
Italy |
2001 – 2005 |
The Health Search/Thales Database |
52.5 (16.5); 47.41 |
52.4 (16.4); 52.59 |
3516 |
399 |
17580 |
1425 |
CVD, PD |
6 |
Yang YW, 20112727 Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol. 2011;165:1037–43.
|
Taiwan |
2006.01 – 2007.12 |
Longitudinal Health Insurance Database2000 |
NR, >18; 32.58 |
NR, >18; 67.42 |
1685 |
1471 |
5055 |
3651 |
CVD, KD, CD, PD, LD |
8 |
Yeung H, 20134040 Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149:1173–9.
|
UK |
NR |
The Health Improvement Network |
46 (37–55); 49.43 |
46 (36–55); 52.91 |
9035 |
1945 |
90350 |
17502 |
CVD, KD, CD, PD, LD |
6 |